- Country: Slovenia
- Summary: Genomic Testing for Early Breast Cancer Treatment Planning
- SLT Ref No: 111569864
- Deadline: 17 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 756290-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The genomic tests OncotypeDX and Mammaprint, in the 3rd phase of clinical studies (TailorX and Mindact), have demonstrated the clinical utility of the 1st level in adjuvant systemic treatment with endocrine therapy and without chemotherapy.
Based on the results, both tests are included in the main international clinical guidelines. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINGenomic Testing for Early Breast Cancer Treatment Planning - Slovenia Tender
The LJUBLJANA INSTITUTE OF ONCOLOGY, a Government sector organization in Slovenia, has announced a new tender for Genomic Testing for Early Breast Cancer Treatment Planning. This tender is published on SloveniaTenders under SLT Ref No: 111569864 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-17.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
